Novo Integrated Sciences Statistics
Share Statistics
Novo Integrated Sciences has 19.05M shares outstanding. The number of shares has increased by 10.2% in one year.
| Shares Outstanding | 19.05M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 17.53M |
| Failed to Deliver (FTD) Shares | 195.42K |
| FTD / Avg. Volume | 35.93% |
Short Selling Information
The latest short interest is 274.86K, so 1.44% of the outstanding shares have been sold short.
| Short Interest | 274.86K |
| Short % of Shares Out | 1.44% |
| Short % of Float | 1.57% |
| Short Ratio (days to cover) | 1.13 |
Valuation Ratios
The PE ratio is -1.08 and the forward PE ratio is null.
| PE Ratio | -1.08 |
| Forward PE | null |
| PS Ratio | 1.13 |
| Forward PS | null |
| PB Ratio | 0.57 |
| P/FCF Ratio | -6.21 |
| PEG Ratio | n/a |
Enterprise Valuation
Novo Integrated Sciences Inc. has an Enterprise Value (EV) of 18.29M.
| EV / Earnings | -1.38 |
| EV / Sales | 1.45 |
| EV / EBITDA | -3.13 |
| EV / EBIT | -2.14 |
| EV / FCF | -7.98 |
Financial Position
The company has a current ratio of 0.56, with a Debt / Equity ratio of 0.09.
| Current Ratio | 0.56 |
| Quick Ratio | 0.42 |
| Debt / Equity | 0.09 |
| Total Debt / Capitalization | 8.65 |
| Cash Flow / Debt | -0.95 |
| Interest Coverage | -1.67 |
Financial Efficiency
Return on equity (ROE) is -0.53% and return on capital (ROIC) is -29.52%.
| Return on Equity (ROE) | -0.53% |
| Return on Assets (ROA) | -0.37% |
| Return on Capital (ROIC) | -29.52% |
| Revenue Per Employee | 98.99K |
| Profits Per Employee | -104.05K |
| Employee Count | 127 |
| Asset Turnover | 0.35 |
| Inventory Turnover | 6.88 |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -97.39% in the last 52 weeks. The beta is -0.66, so Novo Integrated Sciences 's price volatility has been lower than the market average.
| Beta | -0.66 |
| 52-Week Price Change | -97.39% |
| 50-Day Moving Average | 0.13 |
| 200-Day Moving Average | 0.45 |
| Relative Strength Index (RSI) | 33.53 |
| Average Volume (20 Days) | 543.86K |
Income Statement
In the last 12 months, Novo Integrated Sciences had revenue of $12.57M and earned -$13.21M in profits. Earnings per share was $-1.3.
| Revenue | 12.57M |
| Gross Profit | 4.95M |
| Operating Income | -8.55M |
| Net Income | -13.21M |
| EBITDA | -5.85M |
| EBIT | -8.55M |
| Earnings Per Share (EPS) | -1.3 |
Balance Sheet
The company has $416.32K in cash and $4.47M in debt, giving a net cash position of -$4.06M.
| Cash & Cash Equivalents | 416.32K |
| Total Debt | 4.47M |
| Net Cash | -4.06M |
| Retained Earnings | -67.03M |
| Total Assets | 35.33M |
| Working Capital | -16.52M |
Cash Flow
In the last 12 months, operating cash flow was -$2.24M and capital expenditures -$49.22K, giving a free cash flow of -$2.29M.
| Operating Cash Flow | -2.24M |
| Capital Expenditures | -49.22K |
| Free Cash Flow | -2.29M |
| FCF Per Share | -0.23 |
Margins
Gross margin is 39.39%, with operating and profit margins of -68.03% and -105.11%.
| Gross Margin | 39.39% |
| Operating Margin | -68.03% |
| Pretax Margin | -105.55% |
| Profit Margin | -105.11% |
| EBITDA Margin | -46.52% |
| EBIT Margin | -68.03% |
| FCF Margin | -18.24% |
Dividends & Yields
NVOS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -4333.33% |
| FCF Yield | -364.59% |
Analyst Forecast
Currently there are no analyst rating for NVOS.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Stock Splits
The last stock split was on Nov 7, 2023. It was a backward split with a ratio of 1:10.
| Last Split Date | Nov 7, 2023 |
| Split Type | backward |
| Split Ratio | 1:10 |
Scores
| Altman Z-Score | -5.37 |
| Piotroski F-Score | 3 |